HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 522 filers reported holding HORIZON THERAPEUTICS PUB L in Q2 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,508,829 | -61.8% | 13,042 | -66.1% | 0.00% | -100.0% |
| Q2 2023 | $3,951,703 | -40.9% | 38,422 | -37.3% | 0.00% | -66.7% |
| Q1 2023 | $6,683,297 | -68.7% | 61,236 | -67.4% | 0.00% | -70.0% |
| Q4 2022 | $21,370,616 | +348.9% | 187,791 | +144.1% | 0.01% | +400.0% |
| Q3 2022 | $4,761,000 | -54.0% | 76,921 | -40.8% | 0.00% | -50.0% |
| Q2 2022 | $10,356,000 | -68.1% | 129,847 | -57.9% | 0.00% | -63.6% |
| Q1 2022 | $32,428,000 | +24.5% | 308,232 | +27.5% | 0.01% | +37.5% |
| Q4 2021 | $26,055,000 | -23.1% | 241,788 | -21.8% | 0.01% | -27.3% |
| Q3 2021 | $33,878,000 | +50.5% | 309,275 | +28.7% | 0.01% | +22.2% |
| Q2 2021 | $22,505,000 | -69.3% | 240,340 | -69.9% | 0.01% | -75.0% |
| Q1 2021 | $73,375,000 | +54.3% | 797,220 | +22.6% | 0.04% | +50.0% |
| Q4 2020 | $47,562,000 | -14.3% | 650,203 | -9.0% | 0.02% | -29.4% |
| Q3 2020 | $55,507,000 | +432.2% | 714,557 | +280.8% | 0.03% | +325.0% |
| Q2 2020 | $10,429,000 | +173.8% | 187,630 | +78.3% | 0.01% | +60.0% |
| Q4 2019 | $3,809,000 | +16.9% | 105,237 | -22.3% | 0.01% | -16.7% |
| Q2 2019 | $3,257,000 | – | 135,362 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |